Clinical Trial Update: Combination Therapy of Umbilical Cord Blood and Erythropoietin for Stroke Paients [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on a combination therapy using umbilical cord blood and erythropoietin for stroke patients across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Erythropoietin (erythropoietin)
• Umbilical Cord Blood

Snippet

Sponsor: Bundang CHA Hospital | Conditions: Stroke, Umbilical Cord Blood | Phase 1, Phase 2 | Status: UNKNOWN